Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam preemptive sedation to prevent propofol injection pain in induced abortion/curettage
ChiCTR2100041805Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in procedural pain (3 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoint: Pain. Started Jan 2021; status: recruiting.
02
Drugs
remimazolam
03
Conditions
procedural pain
Beyond the preview
Go deeper on ChiCTR2100041805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100041805.